RxSight enters CFO transition agreement with Thunen; reaffirms 2025 outlook

RxSight, Inc.

Shelley Thunen transitions from CFO; transition and consulting agreements executed effective Dec 23, 2025.
Company reaffirms full-year 2025 outlook unchanged by CFO transition.
Transition was previously announced; material terms incorporated by reference from Dec 22, 2025 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.